Form 4 for CGTX COGNITION THERAPEUTICS INC
Accepted 2025-07-31 00:00:00 ET · period of report 2025-07-29 · accession 0001062993-25-013357 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-31 | 2025-07-29 | CGTX | Doyle John Brendan | CFO | A - Grant | $0.00 | +30.0K | 434.7K | +7% | $0 | |
| 2025-07-31 | 2025-07-29 | CGTX | Doyle John Brendan | CFO | F - Tax | $0.67 | -9,360 | 425.4K | -2% | -$6,271 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-29 | A | A | 30,000 | $0.00 | 434,710 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-29 | F | D | 9,360 | $0.67 | 425,350 | D | — | — |